Home Newsletters Mesenchymal Cell News CD90low Glioma-Associated Mesenchymal Stromal/Stem Cells Promote Temozolomide Resistance by Activating FOXS1-Mediated Epithelial-Mesenchymal...

CD90low Glioma-Associated Mesenchymal Stromal/Stem Cells Promote Temozolomide Resistance by Activating FOXS1-Mediated Epithelial-Mesenchymal Transition in Glioma Cells

By
Justin.choi
-
0
Scientists explored the effect and mechanism of glioma-associated MSCs on resistance to temozolomide in glioma cells.
[Stem Cell Research & Therapy]

Sorry, but the selected Zotpress account can't be found.

Full Article

RELATED ARTICLES

Exit mobile version